Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion — CRVO

Central Retinal Vein Occlusion With Macular Edema Clinical Trial

Official title:
Comparison of Intravitreal Bevacizumab and Triamcinolone Acetonide With Intravitreal Bevacizumab Alone in Macular Edema Secondary to Central Retinal Vein Occlusion

Status Completed

Clinical Trial Summary

To compare the effect of intravitreal-Bevacizumab and Triamcinolone with intravitreal-Bevacizumab alone on visual acuity and central foveal thickness in patients with macular edema secondary to central retinal vein occlusion.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04812977
Study type	Interventional
Source	Hayatabad Medical Complex
Contact
Status	Completed
Phase	N/A
Start date	June 10, 2018
Completion date	December 10, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02556723` - Intravitreal Injections of Ziv-aflibercept for Macular Diseases	N/A
Completed	`NCT02006147` - Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO	Phase 1/Phase 2
Completed	`NCT05832996` - Cool vs Room-temperature Artificial Tears	Phase 4
Completed	`NCT04290195` - Use of Ziv Aflibercept in Different Retinal Diseases	Phase 1/Phase 2
Recruiting	`NCT04444492` - Combination of Ranibizumab and Targeted Laser Photocoagulation	Phase 3
Not yet recruiting	`NCT02522897` - Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas	Phase 4